On February 24, 2025 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, reported participation in three upcoming investor conferences (Press release, Ultragenyx Pharmaceutical, FEB 24, 2025, View Source [SID1234650481]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

45th Annual Cowen Healthcare Conference (Boston, MA)

Monday, March 3, 2025, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1×1 meetings.
Barclays 27th Annual Global Healthcare Conference (Miami, FL)

Tuesday, March 11, 2025, Eric Crombez will participate in a fireside chat and host 1×1 meetings.
Leerink Partners Global Biopharma Conference (Miami, FL)

Wednesday, March 12, 2025, Eric Crombez will participate in a fireside chat and host 1×1 meetings.
The live and archived webcast of the fireside chat will be accessible from the company’s website at View Source